Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

51.1K
Overview
51.1K
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

17.8K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.8K
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

262
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
262
Steps in Outbreak Investigation01:18

Steps in Outbreak Investigation

468
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
468
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

1.3K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.3K
Nondisjunction01:21

Nondisjunction

4.8K
Nondisjunction is the failure of homologous chromosomes or sister chromatids to separate correctly and move to the opposite poles of the cells. This produces daughter cells with abnormal chromosome numbers.  Nondisjunction is common during anaphase I or anaphase II of meiosis.  Mutations in synaptonemal complex proteins that attach homologous chromosomes increase the chances of nondisjunction in anaphase I of meiosis I. In contrast, mutations in topoisomerases and condensins that hold...
4.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

Lyme disease in Poland in 2023.

Przeglad epidemiologiczny·2026
Same authorSame journal

Pertussis in Poland in 2023.

Przeglad epidemiologiczny·2026
Same author

Public spending on immunisation in Poland.

Frontiers in public health·2025
Same author

Chickenpox in Poland in 2023.

Przeglad epidemiologiczny·2025
Same author

Measles in Poland: 2022-2023.

Przeglad epidemiologiczny·2025
Same author

Rubella in Poland: 2022-2023.

Przeglad epidemiologiczny·2025
Same journal

Infectious diseases in Poland in 2023.

Przeglad epidemiologiczny·2026
Same journal

Foodborne infections and intoxications in Poland in 2021-2023.

Przeglad epidemiologiczny·2026
Same journal

Salmonellosis in Poland in 2023.

Przeglad epidemiologiczny·2026
Same journal

Tuberculosis in Poland in 2023.

Przeglad epidemiologiczny·2026
See all related articles

Related Experiment Video

Updated: Jan 8, 2026

Merkel Cell Polyomavirus Infection and Detection
13:45

Merkel Cell Polyomavirus Infection and Detection

Published on: February 7, 2019

10.3K

Mumps in Poland in 2023.

Karolina Mrozowska-Nyckowska1, Iwona Paradowska-Stankiewicz1

  • 1Zakład Epidemiologii Chorób Zakaźnych i Nadzoru, Narodowy Instytut Zdrowia Publicznego PZH - Państwowy Instytut Badawczy.

Przeglad Epidemiologiczny
|December 12, 2025
PubMed
Summary
This summary is machine-generated.

Mumps cases increased in Poland in 2023, but remain below pre-pandemic levels. The COVID-19 pandemic temporarily reduced mumps transmission due to public health restrictions.

Keywords:
20232023 rokPolandPolskaepidemic parotitis epidemiologyepidemiologiamumpsnagminne zapalenie przyusznicświnka

More Related Videos

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
08:47

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Published on: March 3, 2023

2.9K
Contact Hypersensitivity as a Murine Model of Allergic Contact Dermatitis
08:25

Contact Hypersensitivity as a Murine Model of Allergic Contact Dermatitis

Published on: September 26, 2022

3.4K

Related Experiment Videos

Last Updated: Jan 8, 2026

Merkel Cell Polyomavirus Infection and Detection
13:45

Merkel Cell Polyomavirus Infection and Detection

Published on: February 7, 2019

10.3K
Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
08:47

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Published on: March 3, 2023

2.9K
Contact Hypersensitivity as a Murine Model of Allergic Contact Dermatitis
08:25

Contact Hypersensitivity as a Murine Model of Allergic Contact Dermatitis

Published on: September 26, 2022

3.4K

Area of Science:

  • Epidemiology
  • Public Health
  • Infectious Diseases

Background:

  • Mumps is a viral illness transmitted person-to-person.
  • Mandatory measles, mumps, and rubella (MMR) vaccination in Poland since 2003 has significantly reduced mumps incidence and complications.
  • Despite high vaccination rates, mumps remains a public health concern.

Purpose of the Study:

  • To assess the 2023 incidence of mumps in Poland.
  • To compare mumps incidence in 2023 with previous years.
  • To evaluate the impact of the COVID-19 pandemic on mumps epidemiology.

Main Methods:

  • Analysis of data from Poland's national epidemiological surveillance system for mumps in 2023.
  • Calculation of incidence rates per 100,000 inhabitants.
  • Estimation of vaccination coverage using cohort data and vaccination effectiveness via the screening method.

Main Results:

  • Poland registered 966 mumps cases in 2023, a 4.8% increase from 2022.
  • The overall incidence rate was 2.6 per 100,000 population, 5.3% higher than in 2022.
  • The highest incidence was observed in children aged 0-9 years and in the Śląskie voivodeship. Hospitalizations decreased by 40%.

Conclusions:

  • An upward trend in mumps cases was observed in 2023.
  • The COVID-19 pandemic temporarily reduced mumps transmission due to restrictions on droplet-spread diseases.
  • Despite the recent increase, mumps incidence in 2023 remains lower than pre-pandemic levels.